Imidazo[1,5-a]pyridine: A Versatile Architecture for Stable N-Heterocyclic Carbenes
摘要:
The imidazo[1,5-a]pyridine skeleton provides a versatile platform for the generation of new types of stable N-heterocyclic carbenes. Rh(I) mono- (6) and biscarbenes (7) from imidazo[1,5-a]pyridin-3-ylidenes (ImPy) and derivatives such as 13 from a mesoionic carbene were synthesized and characterized.
Imidazo[1,5-a]pyridine: A Versatile Architecture for Stable N-Heterocyclic Carbenes
摘要:
The imidazo[1,5-a]pyridine skeleton provides a versatile platform for the generation of new types of stable N-heterocyclic carbenes. Rh(I) mono- (6) and biscarbenes (7) from imidazo[1,5-a]pyridin-3-ylidenes (ImPy) and derivatives such as 13 from a mesoionic carbene were synthesized and characterized.
Method for treating neurological disorders with imidazolium and imidazolinium compounds
申请人:Agency for Science, Technology and Research
公开号:EP2803356A1
公开(公告)日:2014-11-19
There is presently provided methods for delivering a neuroprotective agent to a neural cell. The methods comprise contacting a neural cell with an imidazolium or imidazolinium compound as described herein, including an imidazolium or imidazolinium salt.
Ru/O<sub>2</sub>-Catalyzed Oxidative C–H Activation/Alkyne Annulation Using Quinoline-Functionalized NHC as a Directing and Functionalizable Group
作者:Monuranjan Konwar、Nitumoni Hazarika、Animesh Das
DOI:10.1021/acs.orglett.4c00542
日期:2024.4.19
The ruthenium/O2-catalyzed oxidative annulation reaction of imidazo[1,5-a]quinolin-2-ium salts with alkynes via N-heterocyclic carbene-directed C–Hactivation to obtain π-conjugated fused imidazo[1,5-a]quinolin-2-ium derivatives is reported. Molecular oxygen has been explored as an economic and clean oxidant and an alternative to metal oxidants. The current protocol exhibits a wide range of substrate
钌/O 2催化咪唑并[1,5- a ]喹啉-2-鎓盐与炔烃通过N-杂环卡宾引导的C-H活化发生氧化成环反应,得到π-共轭稠合咪唑[1,5-报道了a ]喹啉-2-鎓衍生物。分子氧已被探索作为一种经济且清洁的氧化剂以及金属氧化剂的替代品。当前的协议展示了广泛的底物范围,包括生物活性 (±)-α-生育酚衍生物。此外,大多数环状产品表现出很强的荧光特性,表明它们具有制造新型发光材料的潜力。
METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
申请人:Zhuo Lang
公开号:US20110028513A1
公开(公告)日:2011-02-03
There is presently provided methods for delivering a neuroprotective agent to a neural cell. The methods comprise contacting a neural cell with an imidazolium or imidazolinium compound as described herein, including an imidazolium or imidazolinium salt.
METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
申请人:Zhuo Lang
公开号:US20110178040A1
公开(公告)日:2011-07-21
There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including imidazolium and imidazolinium salts.